Cargando…
Management and Complications of Dexamethasone Intravitreal Implant Migration Into the Anterior Chamber
PURPOSE: To report patient demographics, the clinical course, and visual outcomes across a case series of patients who experienced dexamethasone (DEX) intravitreal implant (Ozurdex, Allergan, Inc) migration into the anterior chamber (AC), with a focus on the corneal transplantation rate. METHODS: In...
Autores principales: | Betsch, Devin M., Gupta, R. Rishi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954786/ https://www.ncbi.nlm.nih.gov/pubmed/37009539 http://dx.doi.org/10.1177/24741264221138166 |
Ejemplares similares
-
Management of Anterior Chamber Migration of Dexamethasone Intravitreal Implant
por: Ha, Jun Young, et al.
Publicado: (2017) -
Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration
por: Röck, D., et al.
Publicado: (2019) -
Anterior chamber migration of intravitreal dexamethasone implant in glued intraocular lens
por: Kumar, Dhivya Ashok, et al.
Publicado: (2019) -
Anterior Chamber Migration of Intravitreal Dexamethasone Implant in an Eye with Scleral-fixated Intraocular Lens
por: Goel, Neha, et al.
Publicado: (2020) -
Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report
por: Pacella, Fernanda, et al.
Publicado: (2016)